Doncaster Royal Infirmary

The trials here

What the 12 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)3 trials
• Dermatomyositis and polymyositis (myositis)2 trials
• Rheumatoid arthritis2 trials
• Aortic stenosis1 trial
• Childhood cancers1 trial
• Heart failure1 trial
• Polycystic kidney disease1 trial
• Prostate cancer1 trial
• Sjögren's disease1 trial
• Stroke1 trial

Phase

• Phase 37 trials
• Phase 22 trials
• Phase 2/31 trial

Status

• Active, not recruiting5 trials
• Recruiting5 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial

Lead sponsor

• Biogen2 trials
• Boehringer Ingelheim2 trials
• Janssen Research & Development, LLC2 trials
• Alfasigma S.p.A.1 trial
• Hoffmann-La Roche1 trial
• and 4 more

Running trials

• Not yet recruiting

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· Phase 2· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  NCT07137598· Phase 2· Hoffmann-La Roche· Source

• Active, not recruiting

  Nipocalimab in Moderate to Severe Sjogren's Disease

  NCT06741969· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

  NCT05895786· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Recruiting

  Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

  NCT04939935· Phase 3· The University of Queensland· Source

  Contact: Mohsen El Kossi, Dr

• Enrolling by invitation

  A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)

  NCT05352919· Phase 3· Biogen· Source

• Active, not recruiting

  A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

  NCT04961567· Phase 3· Biogen· Source

• Active, not recruiting

  Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis

  NCT04871919· Alfasigma S.p.A.· Source

• Recruiting

  The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study

  NCT04204915· University of Leicester· Source

  Contact: Dr Gillian Payne

• Active, not recruiting

  Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy

  NCT00268476· Phase 2/3· Medical Research Council· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Dermatomyositis and polymyositis (myositis)2 recruiting
• Lupus (SLE)2 recruiting
• Aortic stenosis1 recruiting
• Heart failure1 recruiting
• Polycystic kidney disease1 recruiting
• Rheumatoid arthritis1 recruiting